SS Innovations Secures Nasdaq Listing
SS Innovations International, Inc. (OTC: SSII), a pioneering entity in the field of surgical robotics, recently announced its approval to uplist to The Nasdaq Capital Market in a significant step towards enhancing its visibility and growth potential. This exciting development will take effect shortly, bringing fresh opportunities for the company and reflecting its commitment to innovation in robotic surgery.
Leadership Insights on Uplisting
Dr. Sudhir Srivastava, the Chairman and CEO of SS Innovations, shared his enthusiasm regarding this milestone. He highlighted that uplisting to Nasdaq is not just about a new trading venue; it symbolizes their commitment to delivering world-class robotic surgical technology. This transition aims to make lifesaving robotic surgery accessible and affordable for patients across the globe.
Strategic Global Expansion Plans
The decision to uplist coincides with SS Innovations’ ambitious plans for global expansion. They are looking to extend their footprint beyond their primary market, entering regions like Nepal, Ecuador, Guatemala, the Philippines, Indonesia, Sri Lanka, and Ukraine. Furthermore, SS Innovations has set its sights on strategic entry into Europe and the United States.
As part of these expansion efforts, the company is actively pursuing EU CE Mark and U.S. FDA approval for its flagship SSi Mantra surgical robotic system, aiming for a launch by late 2025 and early 2026, respectively. The uplisting is expected to amplify awareness of their growth trajectory while improving transparency and attracting a wider base of potential investors.
Noteworthy Achievements in Robotic Surgery
In addition to the uplisting announcement, there are several noteworthy accomplishments attributed to SS Innovations. The company has successfully installed 80 SSi Mantra systems in hospitals, resulting in over 3,500 surgeries, including more than 195 robotic cardiac procedures with no reported device-related fatalities or complications. SS Innovations has also achieved a remarkable revenue growth of approximately 251% from the previous year, with 2024 revenues reported at $20.6 million and a gross margin enhancement from 12.3% in 2023 to 40.9%.
Innovations Behind the SSi Mantra
The recognition of the company’s innovative approach lies in the features of their SSi Mantra Surgical Robotic System. This system showcases versatility with its modular design, accommodating three to five robotic arms. It features an ergonomic command center for surgeons and advanced imaging capabilities that enhance surgical precision and safety. Moreover, the SSi Mantra has been clinically validated in various surgical procedures, proving its efficacy in improving patient outcomes.
Continued Commitment to Accessibility
At the core of SS Innovations' mission is the goal of democratizing access to advanced surgical technologies. They aim to bridge the gap between sophisticated healthcare technology and affordable patient care. With the uplift to Nasdaq, the company seeks to further its outreach and innovate solutions that cater to a larger audience, particularly in underserved regions.
Investor Relations and Contacts
The success of SS Innovations is bolstered by robust investor relations initiatives. Investors can reach out to Kalle Ahl at The Equity Group for inquiries at (303) 953-9878 or via email. Additionally, Devin Sullivan is available for further assistance at (212) 836-9608.
The media contact for further updates includes a dedicated press email. SS Innovations encourages interested parties to stay updated on their developments by connecting via email.
Frequently Asked Questions
What does the uplisting to Nasdaq mean for SS Innovations?
The uplisting signifies enhanced market visibility and credibility, potentially attracting more investors and resources for growth.
What is the SSi Mantra surgical robotic system?
The SSi Mantra is a modular, advanced surgical system designed to improve the quality and accessibility of robotic surgeries.
How is SS Innovations expanding globally?
SS Innovations aims to penetrate markets in Nepal, Ecuador, and the United States, planning regulatory approvals for their robotic systems.
What growth has SS Innovations experienced recently?
In 2024, the company reported a 251% increase in revenue, reflecting its successful operational advancements and market acceptance.
How can investors contact SS Innovations for more information?
Investors can reach out to Kalle Ahl or Devin Sullivan via phone or email for inquiries related to investments and business communications.
